PRESS RELEASE published on 03/10/2025 at 21:09, 10 months 22 days ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 03/10/2025 at 21:09, 10 months 22 days ago Sanofi : Déclaration des transactions sur actions propres
BRIEF published on 03/08/2025 at 19:05, 10 months 24 days ago Sanofi-Aventis Reports Positive Data for Dupixent in Bullous Pemphigoid Clinical Study Dupixent Type 2 Inflammation Bullous Pemphigoid Regulatory Review
BRIEF published on 03/08/2025 at 19:05, 10 months 24 days ago Sanofi-Aventis publie des données positives sur Dupixent dans le traitement de la pemphigoïde bulleuse Étude Clinique Dupixent Pemphigoïde Bulleuse Examen Réglementaire Inflammation De Type 2
PRESS RELEASE published on 03/08/2025 at 19:00, 10 months 24 days ago Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
BRIEF published on 02/25/2025 at 07:05, 11 months 4 days ago Sarclisa Gains Approval in Japan for Multiple Myeloma Treatment Multiple Myeloma Sarclisa Approval Sanofi Oncology Japan Healthcare IMROZ Study
BRIEF published on 02/25/2025 at 07:05, 11 months 4 days ago Sarclisa obtient l'approbation au Japon pour le traitement du myélome multiple Myélome Multiple Étude IMROZ Approbation De Sarclisa Sanofi Oncologie Système De Santé Au Japon
PRESS RELEASE published on 02/25/2025 at 07:00, 11 months 4 days ago Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Sarclisa approved in Japan for newly diagnosed multiple myeloma patients, offering new treatment options based on positive IMROZ phase 3 study results Oncology Japan Multiple Myeloma Sarclisa IMROZ Study
PRESS RELEASE published on 02/24/2025 at 21:27, 11 months 5 days ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 02/24/2025 at 21:27, 11 months 5 days ago Sanofi: Disclosure of trading in own shares
Published on 02/02/2026 at 00:05, 49 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 1 day 21 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 23 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/01/2026 at 20:25, 4 hours 28 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 8 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 12 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 22 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days 2 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 18:40, 2 days 6 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 7 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 7 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 16 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés